FDA Approved: LEVETIRACETAM — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for levetiracetam submitted by BluePoint Laboratories, enabling the generic product’s approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)